SafeBreach software helped a Fortune 500 biopharmaceutical company reduce endpoint tool sprawl and risks by establishing continuous security control validation. Facing growing complexity from proliferating tools, the security team used SafeBreach's safe, automated attack simulations to rigorously test endpoint safeguards. This provided knowledgeable assessments of tool effectiveness, enabling informed consolidation, minimized costs, and optimized defenses. SafeBreach ensured the most effective protections with reduced overhead, empowering resilient security for critical biopharma operations.

Join for free to read